Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Neoplasms by Site × ribociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 Breast 1

Conditions

Breast Neoplasms 2 Neoplasms by Site 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Breast Diseases 1 Advanced Metastatic Breast Cancer 1

Interventions

selpercatinib 2 ribociclib 1 repotrectinib 1 pralsetinib 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02422615 2023-11-30

MONALEESA-3

Novartis

Phase 3 Completed

726 enrolled 17 charts 1 FDA

BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡